Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.
暂无分享,去创建一个
D. Lockhart | J. Welsh | L. Sapinoso | S. Kern | G. Hampton | P. Zarrinkar | C. Behling | B. Monk | R. Burger
[1] R. Bast,et al. Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. , 1984, American journal of obstetrics and gynecology.
[2] R. Stahel,et al. CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. , 1992, Cancer research.
[3] R. Souhami,et al. The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies. , 1994, British Journal of Cancer.
[4] M. Hearn,et al. Aberrant FGF-2, FGF-3, FGF-4 and C-erb-B2 gene copy number in human ovarian, breast and endometrial tumours. , 1996, Growth factors.
[5] S. Ishiguro,et al. Immunohistochemically detected expression of motility‐related protein‐1 (MRP‐1/CD9) in lung adenocarcinoma and its relation to prognosis , 1997, International journal of cancer.
[6] B. Sordat,et al. Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. , 1997, Cancer research.
[7] L. Wodicka,et al. Genome-wide expression monitoring in Saccharomyces cerevisiae , 1997, Nature Biotechnology.
[8] G. Gatta,et al. Survival of European women with gynaecological tumours, during the period 1978-1989. EUROCARE Working Group. , 1998, European journal of cancer.
[9] Klaus Ley,et al. CD24 mediates rolling of breast carcinoma cells on P‐selectin , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[11] K. Cole,et al. Histopathology and molecular biology of ovarian epithelial tumors. , 1998, Annals of diagnostic pathology.
[12] P. Altevogt,et al. CD24 is a marker for human breast carcinoma. , 1999, Cancer letters.
[13] U. Alon,et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Inoue,et al. CD9 is involved in invasion of human trophoblast-like choriocarcinoma cell line, BeWo cells. , 1999, Molecular human reproduction.
[15] S. P. Fodor,et al. High density synthetic oligonucleotide arrays , 1999, Nature Genetics.
[16] Roger E Bumgarner,et al. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. , 1999, Gene.
[17] G. Rustin,et al. Role of tumour markers in monitoring epithelial ovarian cancer , 2000, British Journal of Cancer.
[18] J W Gray,et al. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. , 2000, Cancer research.
[19] T Tanaka,et al. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. , 2000, Cancer research.
[20] Y. Bignon,et al. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). , 2000, International journal of oncology.
[21] Emanuel Petricoin,et al. Molecular profiling of human cancer , 2000, Nature Reviews Genetics.